Study Links High Doses of Medtronic Infuse and Cancer Risk
Medtronic Infuse at high doses appears to increase the risk of new cancers, according to the findings of a new study.
September 18, 2013 By: Irvin Jackson
Medtronic Infuse at high doses appears to increase the risk of new cancers, according to the findings of a new study.
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.